{"component": "definition", "props": {"groups": [{"size": 14, "snippet": "means the group purchasing of insurance/reinsurance or the setting aside of funds and reserves to pay for a self-insured retention or for losses not covered by insurance/reinsurance.", "samples": [{"hash": "eoTaBTws3nU", "uri": "/contracts/eoTaBTws3nU#joint-program", "label": "Joint Exercise of Powers Agreement", "score": 19.0, "published": true}, {"hash": "1Omjqb5j2Sb", "uri": "/contracts/1Omjqb5j2Sb#joint-program", "label": "Joint Exercise of Powers Agreement", "score": 19.0, "published": true}, {"hash": "2bVp1BPnBpd", "uri": "https://www.alvordschools.org:443/cms/lib8/CA01900929/Centricity/Domain/42/2016-06-23/Docs/12.pdf", "label": "www.alvordschools.org:443", "score": 7.841889117, "published": false}], "snippet_links": [{"key": "group-purchasing", "type": "clause", "offset": [10, 26]}, {"key": "pay-for", "type": "definition", "offset": [98, 105]}, {"key": "insured-retention", "type": "clause", "offset": [113, 130]}, {"key": "not-covered-by-insurance", "type": "clause", "offset": [145, 169]}], "hash": "0ef84b1d7b5ec90687840867aa52ddbb", "id": 1}, {"size": 4, "snippet": "means the program of Joint works or measures referred to in sub\u2011clause 10(1);", "samples": [{"hash": "c80ftTTblX8", "uri": "https://www.legislation.gov.au/Details/C2008B00243", "label": "www.legislation.gov.au", "score": 10.1704312115, "published": false}, {"hash": "3299izWVbN7", "uri": "https://www.legislation.gov.au/Details/C2008A00139", "label": "www.legislation.gov.au", "score": 10.1704312115, "published": false}, {"hash": "7lArMSFS45Q", "uri": "https://www.legislation.gov.au/Details/C2008B00243/811996a0-622c-4f00-a9e5-81c33b12d573", "label": "www.legislation.gov.au", "score": 7.1704312115, "published": false}], "snippet_links": [{"key": "the-program", "type": "clause", "offset": [6, 17]}, {"key": "joint-works", "type": "clause", "offset": [21, 32]}, {"key": "measures-referred", "type": "clause", "offset": [36, 53]}], "hash": "135bd11d2a7b095d7490e63897d5ab8b", "id": 2}, {"size": 3, "snippet": "means the program of Joint works or measures referred to in sub-clause 10(1);", "samples": [{"hash": "t8swLb3Rq5", "uri": "/contracts/t8swLb3Rq5#joint-program", "label": "Murray Darling Basin Agreement", "score": 19.0, "published": true}, {"hash": "jsYtilMwZIw", "uri": "/contracts/jsYtilMwZIw#joint-program", "label": "Murray Darling Basin Agreement", "score": 19.0, "published": true}, {"hash": "2ZhbMzhBlHU", "uri": "https://www.legislation.gov.au/Details/C2017C00151/a28636a1-07a8-4e1f-b75c-c945824c627f", "label": "www.legislation.gov.au", "score": 10.1704312115, "published": false}], "snippet_links": [{"key": "the-program", "type": "clause", "offset": [6, 17]}, {"key": "joint-works", "type": "clause", "offset": [21, 32]}, {"key": "measures-referred", "type": "clause", "offset": [36, 53]}], "hash": "4cc01f45cb2346ae1d352e078e4c00a1", "id": 3}, {"size": 3, "snippet": "means the group purchasing of Insurance, or the pooled purchase of Excess Insurance with the setting aside of funds and reserves to pay for a self-insured retention or for losses not covered by insurance.", "samples": [{"hash": "RSFmgqbNt", "uri": "/contracts/RSFmgqbNt#joint-program", "label": "Joint Powers Agreement", "score": 26.2252583046, "published": true}, {"hash": "EGvco0HUrk", "uri": "https://mtdiablo.ic-board.com/attachments/c3ef7091-f93f-4041-b099-32b7ba871c4f.pdf", "label": "mtdiablo.ic-board.com", "score": 9.5735797399, "published": false}, {"hash": "4a9oQLsCJVf", "uri": "https://svusd.ic-board.com:443/attachments/8321a5cd-94b2-4f82-837b-53ed4fbb8d08.pdf", "label": "svusd.ic-board.com:443", "score": 5.7104722793, "published": false}], "snippet_links": [{"key": "group-purchasing", "type": "clause", "offset": [10, 26]}, {"key": "excess-insurance", "type": "definition", "offset": [67, 83]}, {"key": "pay-for", "type": "definition", "offset": [132, 139]}, {"key": "insured-retention", "type": "clause", "offset": [147, 164]}, {"key": "not-covered-by-insurance", "type": "clause", "offset": [179, 203]}], "hash": "b573930d1842ec91d83b168d679e6ac7", "id": 4}, {"size": 2, "snippet": "means the coverage for property and liability claims in excess of the Member\u2019s retention pursuant to the terms of NCSIG\u2019s coverage documents along with the purchasing of insurance or reinsurance or the setting aside of funds and reserves to pay for a self-insured retention or for losses not covered by insurance or reinsurance of such claims.", "samples": [{"hash": "eG3vE7ev6jc", "uri": "https://www.siskiyoucoe.net/cms/lib/CA01001605/Centricity/Domain/28/January%202018%20Board%20Packet.pdf", "label": "www.siskiyoucoe.net", "score": 8.9945242984, "published": false}], "snippet_links": [{"key": "coverage-for", "type": "clause", "offset": [10, 22]}, {"key": "liability-claims", "type": "clause", "offset": [36, 52]}, {"key": "the-member", "type": "definition", "offset": [66, 76]}, {"key": "terms-of", "type": "clause", "offset": [105, 113]}, {"key": "coverage-documents", "type": "clause", "offset": [122, 140]}, {"key": "pay-for", "type": "definition", "offset": [241, 248]}, {"key": "insured-retention", "type": "clause", "offset": [256, 273]}, {"key": "not-covered-by-insurance", "type": "clause", "offset": [288, 312]}], "hash": "be1f62d75b622d9138a63f69e8f1bedc", "id": 5}, {"size": 1, "snippet": "means the activities agreed by the Parties to be jointly undertaken under this Agreement for developing and obtaining Regulatory Approval to Commercialize the Product in the EU and in the U.S. as described in the JDP. For clarity, the Joint Program shall exclude all Clinical Trial and Clinical related activities after March 31, 2010.", "samples": [{"hash": "krvyyVxP8Fx", "uri": "https://investors.durect.com/static-files/c81e349b-6ec5-49bb-b777-c3e3b4472b0a", "label": "investors.durect.com", "score": 7.7405886379, "published": false}], "snippet_links": [{"key": "the-activities", "type": "clause", "offset": [6, 20]}, {"key": "by-the-parties", "type": "clause", "offset": [28, 42]}, {"key": "agreement-for", "type": "clause", "offset": [79, 92]}, {"key": "obtaining-regulatory-approval", "type": "clause", "offset": [108, 137]}, {"key": "to-commercialize", "type": "definition", "offset": [138, 154]}, {"key": "the-product", "type": "clause", "offset": [155, 166]}, {"key": "the-eu", "type": "clause", "offset": [170, 176]}, {"key": "the-us", "type": "clause", "offset": [184, 191]}, {"key": "for-clarity", "type": "clause", "offset": [218, 229]}, {"key": "the-joint", "type": "clause", "offset": [231, 240]}, {"key": "clinical-trial", "type": "clause", "offset": [267, 281]}, {"key": "related-activities", "type": "clause", "offset": [295, 313]}, {"key": "after-march", "type": "clause", "offset": [314, 325]}], "hash": "9f1b0a33e051b6849b7bc571c82b9f4f", "id": 6}, {"size": 1, "snippet": "or \u201cFROG Program\u201d: shall mean the Works performed in accordance with the provisions of a Feasibility Study and then a Work Order, and funded by at least two Funding Parties, as set forth in Article 6 of the Agreement.", "samples": [{"hash": "khFYsECf7DC", "uri": "https://www.framatome.com/frog/docs/default-source/default-document-library/membership-agreement-for-frog-web-site.pdf", "label": "www.framatome.com", "score": 7.2169746749, "published": false}], "snippet_links": [{"key": "the-works", "type": "clause", "offset": [30, 39]}, {"key": "in-accordance-with", "type": "definition", "offset": [50, 68]}, {"key": "the-provisions-of-a", "type": "clause", "offset": [69, 88]}, {"key": "feasibility-study", "type": "clause", "offset": [89, 106]}, {"key": "work-order", "type": "definition", "offset": [118, 128]}, {"key": "funding-parties", "type": "clause", "offset": [157, 172]}, {"key": "article-6", "type": "definition", "offset": [190, 199]}, {"key": "the-agreement", "type": "clause", "offset": [203, 216]}], "hash": "29e260e0a0515a01400a3c2c2a76db1f", "id": 7}, {"size": 1, "snippet": "means the activities agreed by the Parties to be jointly undertaken under this Agreement for developing and obtaining Regulatory Approval to Commercialize the Product in the EU and in the U.S. as described in the JDP. For clarity, the Joint Program shall exclude all Clinical Trial and Clinical related activities after March 31, 2010. Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidential treatment request. Omissions are designated as * * *. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.", "samples": [{"hash": "468k6fnP65R", "uri": "/contracts/468k6fnP65R#joint-program", "label": "Development and License Agreement (Durect Corp)", "score": 21.3531827515, "published": true}], "snippet_links": [{"key": "the-activities", "type": "clause", "offset": [6, 20]}, {"key": "by-the-parties", "type": "clause", "offset": [28, 42]}, {"key": "agreement-for", "type": "clause", "offset": [79, 92]}, {"key": "obtaining-regulatory-approval", "type": "clause", "offset": [108, 137]}, {"key": "to-commercialize", "type": "definition", "offset": [138, 154]}, {"key": "the-product", "type": "clause", "offset": [155, 166]}, {"key": "the-eu", "type": "clause", "offset": [170, 176]}, {"key": "the-us", "type": "clause", "offset": [184, 191]}, {"key": "for-clarity", "type": "clause", "offset": [218, 229]}, {"key": "the-joint", "type": "clause", "offset": [231, 240]}, {"key": "clinical-trial", "type": "clause", "offset": [267, 281]}, {"key": "related-activities", "type": "clause", "offset": [295, 313]}, {"key": "after-march", "type": "clause", "offset": [314, 325]}, {"key": "this-exhibit", "type": "definition", "offset": [394, 406]}, {"key": "the-information", "type": "clause", "offset": [438, 453]}, {"key": "subject-to-the", "type": "definition", "offset": [454, 468]}, {"key": "confidential-treatment-request", "type": "definition", "offset": [469, 499]}, {"key": "filed-separately-with-the-securities-and-exchange-commission", "type": "clause", "offset": [580, 640]}], "hash": "a2500d56f59e219415c07ff6e91843b0", "id": 8}, {"size": 1, "snippet": "means the group purchasing of insurance or the funding of loss to be paid by the group.", "samples": [{"hash": "5mAuestTJvG", "uri": "/contracts/5mAuestTJvG#joint-program", "label": "Joint Powers Agreement", "score": 22.7385352498, "published": true}], "snippet_links": [{"key": "group-purchasing", "type": "clause", "offset": [10, 26]}, {"key": "the-funding", "type": "clause", "offset": [43, 54]}, {"key": "loss-to", "type": "clause", "offset": [58, 65]}, {"key": "by-the-group", "type": "clause", "offset": [74, 86]}], "hash": "6afb768b1c13e7a775af542ae9fc37bd", "id": 9}, {"size": 1, "snippet": "shall be substituted in lieu of \u201cDevelopment Program\u201d in each instance of its occurrence in the Agreement.", "samples": [{"hash": "468k6fnP65R", "uri": "/contracts/468k6fnP65R#joint-program", "label": "Development and License Agreement (Durect Corp)", "score": 21.3531827515, "published": true}], "snippet_links": [{"key": "in-lieu-of", "type": "clause", "offset": [21, 31]}, {"key": "development-program", "type": "definition", "offset": [33, 52]}, {"key": "in-the-agreement", "type": "clause", "offset": [89, 105]}], "hash": "c71109d02b1f1822412b79440eac1684", "id": 10}], "next_curs": "CloSVGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjYLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIWam9pbnQtcHJvZ3JhbSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Joint Program", "size": 30, "snippet": "means the group purchasing of insurance/reinsurance or the setting aside of funds and reserves to pay for a self-insured retention or for losses not covered by insurance/reinsurance.", "id": "joint-program", "examples": ["The Parties shall guide the development, coordination and implementation of the <strong>Joint Program</strong> of Scientific Research and Monitoring.", "The Parties agree to establish, within two years of the entry into force of this Agreement, a <strong>Joint Program</strong> of Scientific Research and Monitoring with the aim of improving their understanding of the ecosystems of the Agreement Area and, in particular, of determining whether fish stocks might exist in the Agreement Area now or in the future that could be harvested on a sustainable basis and the possible impacts of such fisheries on the ecosystems of the Agreement Area.", "The Parties shall ensure that the <strong>Joint Program</strong> of Scientific Research and Monitoring takes into account the work of relevant scientific and technical organizations, bodies and programs, as well as indigenous and local knowledge.", "The Parties are encouraged to conduct scientific research under the framework of the <strong>Joint Program</strong> of Scientific Research and Monitoring established pursuant to Article 4 and under their respective national scientific programs.", "To promote implementation of this Agreement, including with respect to the <strong>Joint Program</strong> of Scientific Research and Monitoring and other activities undertaken pursuant to Article 4, the Parties may form committees or similar bodies in which representatives of Arctic communities, including Arctic indigenous peoples, may participate.", "As part of the <strong>Joint Program</strong> of Scientific Research and Monitoring, the Parties shall adopt, within two years of the entry into force of this Agreement, a data sharing protocol and shall share relevant data, directly or through relevant scientific and technical organizations, bodies and programs, in accordance with that protocol.", "ImmunoGen, acting through patent counsel or agents of its choice, shall be responsible, at its sole cost and expense and in its sole discretion, for the preparation, filing, prosecution and maintenance of all Licensed Patent Rights (other than Licensed Patent Rights claiming <strong>Joint Program</strong> Technology or Joint Improvements).", "The Parties shall also jointly own any Patent Rights claiming such <strong>Joint Program</strong> Technology and Joint Improvements.", "Each Party shall provide to the other Party any invention disclosure related to any <strong>Joint Program</strong> Technology or Joint Improvements within [***] days after such Party receives such disclosure from its employees or others obligated to assign or license inventions to such Party or any Affiliate of such Party.", "ImmunoGen shall not become an assignee of Novartis\u2019 interest in such Patent Rights claiming Novartis Improvements or <strong>Joint Program</strong> Technology as a result of its assumption of such responsibility."], "related": [["development-program", "Development Program", "Development Program"], ["pilot-program", "Pilot program", "Pilot program"], ["marketing-program", "Marketing program", "Marketing program"], ["commercialization-plan", "Commercialization Plan", "Commercialization Plan"], ["pebb-program", "PEBB program", "PEBB program"]], "related_snippets": [], "updated": "2025-07-06T21:56:50+00:00"}, "json": true, "cursor": ""}}